2022
DOI: 10.1186/s12864-021-08258-x
|View full text |Cite
|
Sign up to set email alerts
|

The interactions between interleukin-1 family genes: IL1A, IL1B, IL1RN, and obesity parameters

Abstract: Background Obesity has been recognized as a worldwide growing problem, producing many pathologies including the promotion of “proinflammatory state.” The etiology of human obesity is still only partially understood; however, the genetic background has been proved. Its nature is complex, and currently, it appears that the combined effects of the interactions among multiple genes should receive more attention. Due to the fact that obesity promotes proinflammatory conditions, in this study, we inv… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
6
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
5
3

Relationship

0
8

Authors

Journals

citations
Cited by 13 publications
(7 citation statements)
references
References 41 publications
0
6
0
Order By: Relevance
“…C-X-C motif chemokine 10 (CXCL10) is a small cytokine belonging to the CXC chemokine family that is correlated and responsible for the greater susceptibility of patients with severe portal hypertension, diabetes, obesity, and lung cancer [ 101 104 ]. Interleukin 1 alpha (IL1A) is a member of the interleukin 1 cytokine family that is involved in the molecular mechanisms of hypertension, diabetes, obesity, and lung cancer [ 88 , 105 107 ]. Interferon regulatory factor 7 (IRF7) is a member of the interferon regulatory transcription factor family and is involved in the pathogenesis of diabetes, obesity, and lung cancer [ 108 110 ].…”
Section: Discussionmentioning
confidence: 99%
“…C-X-C motif chemokine 10 (CXCL10) is a small cytokine belonging to the CXC chemokine family that is correlated and responsible for the greater susceptibility of patients with severe portal hypertension, diabetes, obesity, and lung cancer [ 101 104 ]. Interleukin 1 alpha (IL1A) is a member of the interleukin 1 cytokine family that is involved in the molecular mechanisms of hypertension, diabetes, obesity, and lung cancer [ 88 , 105 107 ]. Interferon regulatory factor 7 (IRF7) is a member of the interferon regulatory transcription factor family and is involved in the pathogenesis of diabetes, obesity, and lung cancer [ 108 110 ].…”
Section: Discussionmentioning
confidence: 99%
“…Furthermore, monocytes and macrophages recruit neutrophils through the interaction of CXCL3 and CXCL8 with CXCR1 and CXCR2. Neutrophils express many IL-1 family genes that have been shown to play a key role in in ammation, brosis, and autoimmune reactions 46,47 . Therefore, IL-1 family interaction may be a reason for promoting collagen deposition in the POP sacral ligament.…”
Section: Discussionmentioning
confidence: 99%
“…Signaling pathways include GPCR ligand binding [89], neutrophil degranulation [90], immune system [91], metabolism of lipids [92] and signal transduction [93] made great contribution to the development of IPF. MAP3K15 [94], PRTN3 [95], CX3CR1 [96], AGRP (agouti related neuropeptide) [97], MPO (myeloperoxidase) [98], CD5L [99], S100A8 [100], NPR3 [101], VEGFD (vascular endothelial growth factor D) [102], CXCL11 [103], IL1A [104], CBS (cystathionine beta-synthase) [105], WNT7A [106], SCD (stearoyl-CoA desaturase) [107], LRP2 [108], SLC6A4 [109], BDNF (brain derived neurotrophic factor) [110], CXCL10 [111], ANGPTL7 [112], S100A9 [113], NPY1R [114], IL1B [115], GPIHBP1 [116], CYP1B1 [117], CD36 [118], MACROD2 [119], TRIB3 [120], SPX (spexin hormone) [121], PCSK9 [122], GPD1 [123], CDH13 [124], FFAR4 [125], FGF2 [126], FASN (fatty acid synthase) [127], DGAT2 [128], DACH1 [129], PNPLA3 [130], FGF9 [131], SLC7A11 [132], CLIC5 [133], VIP (vasoactive intestinal peptide) [134], SMAD6 [135], BMPR2 [136], APOA1 [137], INSIG1 [138], TLR3 [139], NLRP12 [140], ADRB1 [141], TLR8 [142], GATA3 [143], CCR2 [144], TLR7 [145], CCRL2 [146], BMPER (BMP binding endothelial regulator) [147], CAV1 [148], TFPI (tissue factor pathway inhibitor) [149], FADS1 [150], SUCNR1 [151], CADM2 [152], SLC19A3 [153], SGCG (sarcoglycan gamma) [154], ADH1B [155], NEGR1 [156], HSD17B12 [157], OXTR (oxytocin receptor) [158] and ANKK1 […”
Section: Discussionmentioning
confidence: 99%